A study to assess the schemas of retreatment with Lutathera in patients with new progression of intestinal well-differentiated neuroendocrine tumor.
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2541272
下载链接
链接失效反馈官方服务：
资源简介：
Primary objectives: To evaluate the efficacy of two additional cycles of Lutathera (one injection every two months), compared to active surveillance during 6 months in patients already retreated with two cycles.
Primary endpoints: Disease Control Rate at 6 months from randomization (defined as Complete Response, Partial Response and Stable Disease from RECIST v1.1) with an evaluation every 2 months.
创建时间：
2021-09-15
